| Tracking the evolution of non–small-cell lung cancer M Jamal-Hanjani, GA Wilson, N McGranahan, NJ Birkbak, TBK Watkins, ... New England Journal of Medicine 376 (22), 2109-2121, 2017 | 2169 | 2017 |
| Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution C Abbosh, NJ Birkbak, GA Wilson, M Jamal-Hanjani, T Constantin, ... Nature 545 (7655), 446-451, 2017 | 1674 | 2017 |
| Allele-specific HLA loss and immune escape in lung cancer evolution N McGranahan, R Rosenthal, CT Hiley, AJ Rowan, TBK Watkins, ... Cell 171 (6), 1259-1271. e11, 2017 | 1154 | 2017 |
| Insertion-and-deletion-derived tumour-specific neoantigens and the immunogenic phenotype: a pan-cancer analysis S Turajlic, K Litchfield, H Xu, R Rosenthal, N McGranahan, JL Reading, ... The lancet oncology 18 (8), 1009-1021, 2017 | 849 | 2017 |
| Tracking cancer evolution reveals constrained routes to metastases: TRACERx renal S Turajlic, H Xu, K Litchfield, A Rowan, T Chambers, JI Lopez, D Nicol, ... Cell 173 (3), 581-594. e12, 2018 | 710 | 2018 |
| Deterministic evolutionary trajectories influence primary tumor growth: TRACERx renal S Turajlic, H Xu, K Litchfield, A Rowan, S Horswell, T Chambers, ... Cell 173 (3), 595-610. e11, 2018 | 543 | 2018 |
| Timing the landmark events in the evolution of clear cell renal cell cancer: TRACERx renal TJ Mitchell, S Turajlic, A Rowan, D Nicol, JHR Farmery, T O’Brien, ... Cell 173 (3), 611-623. e17, 2018 | 463 | 2018 |
| Fc-optimized anti-CD25 depletes tumor-infiltrating regulatory T cells and synergizes with PD-1 blockade to eradicate established tumors FA Vargas, AJS Furness, I Solomon, K Joshi, L Mekkaoui, MH Lesko, ... Immunity 46 (4), 577-586, 2017 | 411 | 2017 |
| Pervasive chromosomal instability and karyotype order in tumour evolution TBK Watkins, EL Lim, M Petkovic, S Elizalde, NJ Birkbak, GA Wilson, ... Nature 587 (7832), 126-132, 2020 | 268 | 2020 |
| Determinants of anti-PD-1 response and resistance in clear cell renal cell carcinoma L Au, E Hatipoglu, MR de Massy, K Litchfield, G Beattie, A Rowan, ... Cancer cell 39 (11), 1497-1518. e11, 2021 | 150 | 2021 |
| A CRISPR/Cas9-Engineered ARID1A-Deficient Human Gastric Cancer Organoid Model Reveals Essential and Nonessential Modes of Oncogenic Transformation YH Lo, KS Kolahi, Y Du, CY Chang, A Krokhotin, A Nair, WD Sobba, ... Cancer discovery 11 (6), 1562-1581, 2021 | 91 | 2021 |
| Escape from nonsense-mediated decay associates with anti-tumor immunogenicity K Litchfield, JL Reading, EL Lim, H Xu, P Liu, M Al-Bakir, YNS Wong, ... Nature communications 11 (1), 3800, 2020 | 74 | 2020 |
| Cell of origin influences pancreatic cancer subtype BM Flowers, H Xu, AS Mulligan, KJ Hanson, JA Seoane, H Vogel, ... Cancer discovery 11 (3), 660-677, 2021 | 73 | 2021 |
| Representative sequencing: unbiased sampling of solid tumor tissue K Litchfield, S Stanislaw, L Spain, LL Gallegos, A Rowan, D Schnidrig, ... Cell reports 31 (5), 2020 | 59 | 2020 |
| Selection of metastasis competent subclones in the tumour interior Y Zhao, X Fu, JI Lopez, A Rowan, L Au, A Fendler, S Hazell, H Xu, ... Nature ecology & evolution 5 (7), 1033-1045, 2021 | 57 | 2021 |
| Spatial patterns of tumour growth impact clonal diversification in a computational model and the TRACERx Renal study X Fu, Y Zhao, JI Lopez, A Rowan, L Au, A Fendler, S Hazell, H Xu, ... Nature ecology & evolution 6 (1), 88-102, 2022 | 33 | 2022 |
| Automated design of paralogue ratio test assays for the accurate and rapid typing of copy number variation CD Veal, H Xu, K Reekie, R Free, RJ Hardwick, D McVey, AJ Brookes, ... Bioinformatics 29 (16), 1997-2003, 2013 | 17 | 2013 |
| PEACE; TRACERx Renal Consortium S Turajlic, H Xu, K Litchfield, A Rowan, T Chambers, JI Lopez, D Nicol, ... Tracking cancer evolution reveals constrained routes to metastases: TRACERx …, 2018 | 11 | 2018 |
| Cell of origin influences pancreatic cancer subtype. Cancer Discov. 2021; 11 (3): 660–677. doi: 10.1158/2159-8290 BM Flowers, H Xu, AS Mulligan, KJ Hanson, JA Seoane, H Vogel, ... CD-20-0633.[PMC free article][PubMed][CrossRef][Google Scholar], 0 | 10 | |
| Consortium TR. 2017 M Jamal-Hanjani, GA Wilson, N McGranahan, NJ Birkbak, TBK Watkins, ... Tracking the Evolution of Non-Small-Cell Lung Cancer. New England Journal of …, 2017 | 5 | 2017 |
